Clover Health Investments, Corp.
CLOV· Nasdaq
Released Mar 12, 2024, after the close
10-K filed Mar 14, 2024, 74 days after period end · 0001801170-24-000064
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $312.39M | — | $432.04M | $166.23M |
| Net Income | -$70.47M |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$84.23M |
| -$187.20M |
| -$126.39M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.